Takeda and Biological E. Limited team up to provide Dengue Vaccine in endemic areas

Takeda and Biological E. Limited Collaborate to Accelerate Access to Dengue Vaccine in Endemic Areas

Takeda and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, yesterday announced a strategic partnership to accelerate access to QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs). These doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest to support National Immunization Programs. […]